155 related articles for article (PubMed ID: 10703533)
1. Endogenous growth hormone secretion does not correlate with growth in patients with Turner's syndrome. Italian Study Group for Turner Syndrome.
Cavallo L; Gurrado R
J Pediatr Endocrinol Metab; 1999; 12(5):623-7. PubMed ID: 10703533
[TBL] [Abstract][Full Text] [Related]
2. Reduced spontaneous growth hormone secretion in patients with Turner's syndrome.
Pirazzoli P; Mazzanti L; Bergamaschi R; Perri A; Scarano E; Nanni S; Zucchini S; Gualandi S; Cicognani A; Cacciari E
Acta Paediatr; 1999 Jun; 88(6):610-3. PubMed ID: 10419243
[TBL] [Abstract][Full Text] [Related]
3. Spontaneous pubertal development in Turner's syndrome. Italian Study Group for Turner's Syndrome.
Pasquino AM; Passeri F; Pucarelli I; Segni M; Municchi G
J Clin Endocrinol Metab; 1997 Jun; 82(6):1810-3. PubMed ID: 9177387
[TBL] [Abstract][Full Text] [Related]
4. Body composition and physical fitness are major determinants of the growth hormone-insulin-like growth factor axis aberrations in adult Turner's syndrome, with important modulations by treatment with 17 beta-estradiol.
Gravholt CH; Naeraa RW; Fisker S; Christiansen JS
J Clin Endocrinol Metab; 1997 Aug; 82(8):2570-7. PubMed ID: 9253336
[TBL] [Abstract][Full Text] [Related]
5. Decreased metabolic clearance of endogenous growth hormone and specific alterations in the pulsatile mode of growth hormone secretion occur in prepubertal girls with Turner's syndrome. Genentech Collaborative Group.
Veldhuis JD; Sotos JF; Sherman BM
J Clin Endocrinol Metab; 1991 Nov; 73(5):1073-80. PubMed ID: 1939522
[TBL] [Abstract][Full Text] [Related]
6. Slow baseline growth and a good response to growth hormone (GH) therapy are related to elevated spontaneous GH pulse frequency in girls with Turner's syndrome.
Kamp GA; Kuilboer MM; Wynne HJ; Rongen-Westerlaken C; Johnson ML; Veldhuis JD; Wit JM
J Clin Endocrinol Metab; 1993 Jun; 76(6):1604-9. PubMed ID: 8501169
[TBL] [Abstract][Full Text] [Related]
7. Influence of spontaneous or induced puberty on the growth promoting effect of treatment with growth hormone in girls with Turner's syndrome.
Massa G; Maes M; Heinrichs C; Vandeweghe M; Craen M; Vanderschueren-Lodeweyckx M
Clin Endocrinol (Oxf); 1993 Mar; 38(3):253-60. PubMed ID: 8458097
[TBL] [Abstract][Full Text] [Related]
8. Effect of obesity on endogenous secretion of growth hormone in Turner's syndrome.
Lu PW; Cowell CT; Jimenez M; Simpson JM; Silink M
Arch Dis Child; 1991 Oct; 66(10):1184-90. PubMed ID: 1953000
[TBL] [Abstract][Full Text] [Related]
9. Final height of patients with Turner's syndrome treated with growth hormone (GH): indications for GH therapy alone at high doses and late estrogen therapy. Italian Study Group for Turner Syndrome.
Cacciari E; Mazzanti L
J Clin Endocrinol Metab; 1999 Dec; 84(12):4510-5. PubMed ID: 10599710
[TBL] [Abstract][Full Text] [Related]
10. Pulsatile growth hormone release in Turner's syndrome and short normal children.
Ghizzoni L; Lamborghini A; Ziveri M; Volta C; Panza C; Balestrazzi P; Bernasconi S
Acta Endocrinol (Copenh); 1990 Sep; 123(3):291-7. PubMed ID: 2239077
[TBL] [Abstract][Full Text] [Related]
11. Decreased growth hormone response to growth hormone-releasing hormone in Turner's syndrome: relation to body weight and adiposity.
Reiter JC; Craen M; Van Vliet G
Acta Endocrinol (Copenh); 1991 Jul; 125(1):38-42. PubMed ID: 1872123
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone secretion in pubertal age patients with Turner's syndrome.
Lanes R; Brito S; Suniaga M; Moncada G; Borges M
J Clin Endocrinol Metab; 1990 Sep; 71(3):770-2. PubMed ID: 2394779
[TBL] [Abstract][Full Text] [Related]
13. Short- and long-term (final height) growth responses to growth hormone (GH) therapy in patients with Turner syndrome: correlation of growth response to stimulated GH levels, spontaneous GH secretion, and karyotype.
Schmitt K; Haeusler G; Blümel P; Plöchl E; Frisch H
Horm Res; 1997; 47(2):67-72. PubMed ID: 9030970
[TBL] [Abstract][Full Text] [Related]
14. Is obesity-related insulin status the cause of blunted growth hormone secretion in Turner's syndrome?
Vaccaro F; Cianfarani S; Pasquino AM; Boscherini B
Metabolism; 1995 Aug; 44(8):1033-7. PubMed ID: 7637644
[TBL] [Abstract][Full Text] [Related]
15. Decreased sensitivity to insulin-like growth factor I in Turner's syndrome: a study of monocytes and T lymphocytes.
Hochberg Z; Aviram M; Rubin D; Pollack S
Eur J Clin Invest; 1997 Jul; 27(7):543-7. PubMed ID: 9263738
[TBL] [Abstract][Full Text] [Related]
16. Final height in girls with Turner's syndrome treated with once or twice daily growth hormone injections. Dutch Advisory Group on Growth Hormone.
Sas TC; de Muinck Keizer-Schrama SM; Stijnen T; van Teunenbroek A; Hokken-Koelega AC; Waelkens JJ; Massa GG; Vulsma T; Gerver WJ; Reeser HM; Delemarre-van de Waal HE; Jansen M; Drop SL
Arch Dis Child; 1999 Jan; 80(1):36-41. PubMed ID: 10325756
[TBL] [Abstract][Full Text] [Related]
17. Final height of growth hormone-treated GH-deficient children and girls with Turner's syndrome: the Dutch experience. The Dutch Advisory Group on Growth Hormone.
de Muinck Keizer-Schrama S; Van den Broeck J; Sas T; Hokken-Koelega A
Horm Res; 1999; 51 Suppl 3():127-31. PubMed ID: 10592457
[TBL] [Abstract][Full Text] [Related]
18. [The GHRH test in Turner's syndrome].
Saggese G; Cesaretti G; Cioni C
Minerva Pediatr; 1991 Jun; 43(6):437-43. PubMed ID: 1886528
[TBL] [Abstract][Full Text] [Related]
19. Serum levels of 20-kilodalton human growth hormone (GH) are parallel those of 22-kilodalton human GH in normal and short children.
Ishikawa M; Yokoya S; Tachibana K; Hasegawa Y; Yasuda T; Tokuhiro E; Hashimoto Y; Tanaka T
J Clin Endocrinol Metab; 1999 Jan; 84(1):98-104. PubMed ID: 9920068
[TBL] [Abstract][Full Text] [Related]
20. Twenty-four hour plasma GH, FSH and LH profiles in patients with Turner's syndrome.
Villadolid MC; Takano K; Hizuka N; Asakawa K; Sukegawa I; Horikawa R; Shizume K
Endocrinol Jpn; 1988 Feb; 35(1):71-81. PubMed ID: 3135180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
